2020
DOI: 10.1038/s41536-019-0086-3
|View full text |Cite
|
Sign up to set email alerts
|

Differential functional roles of fibroblasts and pericytes in the formation of tissue-engineered microvascular networks in vitro

Abstract: Formation of a perfusable microvascular network (μVN) is critical for tissue engineering of solid organs. Stromal cells can support endothelial cell (EC) self-assembly into a μVN, but distinct stromal cell populations may play different roles in this process. Here we describe the differential effects that two widely used stromal cell populations, fibroblasts (FBs) and pericytes (PCs), have on μVN formation. We examined the effects of adding defined stromal cell populations on the self-assembly of ECs derived f… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
44
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(46 citation statements)
references
References 48 publications
0
44
2
Order By: Relevance
“…CXCL12 has also been reported to promote early vascular formation when co-administered with MSC, which was equivalent to MSC co-administration of endothelial progenitor cells [ 114 ]. In contrast, the Food and Drug Administration (FDA) approved C-X-C chemokine receptor type 4 (CXCR4) antagonist, AMD3100, also activates MSC mobilization within the circulation, which assisted in femoral and spinal bone regeneration [ 115 , 116 ]. These observations suggest that CXCL12 can be utilized in multiple ways to help facilitate MSC mediated bone regeneration.…”
Section: Bmsc Treatment For Bone Related Skeletal Diseases/disordementioning
confidence: 99%
“…CXCL12 has also been reported to promote early vascular formation when co-administered with MSC, which was equivalent to MSC co-administration of endothelial progenitor cells [ 114 ]. In contrast, the Food and Drug Administration (FDA) approved C-X-C chemokine receptor type 4 (CXCR4) antagonist, AMD3100, also activates MSC mobilization within the circulation, which assisted in femoral and spinal bone regeneration [ 115 , 116 ]. These observations suggest that CXCL12 can be utilized in multiple ways to help facilitate MSC mediated bone regeneration.…”
Section: Bmsc Treatment For Bone Related Skeletal Diseases/disordementioning
confidence: 99%
“…SCs are sensitive to their surrounding niche, which consists of several cell types, including fibroblasts, endothelial cells, immune cells, and inflammatory cells. These cells have been shown to mediate the proliferation and differentiation of SCs [ 29 , 30 ]. In particular, it has been reported that fibroblasts significantly modulate the SC niche and that after injury, the absence of fibroblasts can lead to the formation of smaller regenerated fibers [ 29 ].…”
Section: Cell Types For the Regeneration Of Skeletal Musclementioning
confidence: 99%
“…iPSCs can be generated in vitro by introducing reprogramming factors, known as Yamanaka factors, into somatic cells. They possess unlimited self-renewal capacity in culture and can be differentiated into almost all cell types [ 30 , 101 ]. Thus, iPSCs offer an attractive option for myogenic regeneration due to their ability to differentiate into myogenic cells [ 19 , 102 ].…”
Section: Cell Types For the Regeneration Of Skeletal Musclementioning
confidence: 99%
“…Another factor affecting adrenergic-cholinergic balance is the upregulation of the neural-crest derived ICA cells, which, however, has only been reported so far in mice [ 22 ]. Given the partial innervation after heart transplantation and the resulting abnormal sympathetic-parasympathetic balance, promoting cardiac innervation opens up a research scope for tissue engineering, e.g., triggering neo-innervation before heart transplantation or prior to implantation [ 216 ].…”
Section: Cardiac Innervation and Heart Diseasementioning
confidence: 99%